Roche has received the FDA priority review for its sBLA for adjuvant Tecentriq and Tecentriq Hybreza in combination with chemotherapy...
Sibel Health has received CE mark certification under the EU MDR for its ANNE One system, designating it as a...
CONNECTA Therapeutics has started a Phase IIa trial to assess CTH120, a neuroplasticity modulator, in adult males with fragile X...
The EMA has validated Bayer's marketing authorisation application for asundexian, an oral Factor XIa inhibitor, to prevent ischaemic stroke.The post...
The UK’s MHRA has announced plans to launch a new AI sandbox to expedite the development of medicines and improve...
Harbour BioMed’s partner Windward Bio has dosed the first patients in the Phase II SIRIUS trial with SKB378 to treat...
Gore has secured CE Mark approval under the MDR for its Gore Viabahn Fortegra venous stent to treat symptomatic IVC...
Medtronic has received the CE mark for its Stealth AXiS surgical system, clearing the way for its use in ENT...
Coya Therapeutics has begun the blinded extension phase of the ALSTARS trial, evaluating the safety and efficacy of COYA 302...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.